TAG:
Omicron variant
IVD Firms Grow During 2022, but COVID-19 Revenue Dropped
By Robert Michel | From the Volume XXIX, No. 7 – May 16, 2022 Issue
MOST MAJOR IN VITRO DIAGNOSTICS (IVD) MANUFACTURERS started strong in 2022 as their base businesses regained steam and made up for the significant falloff in COVID-19 diagnostic test revenue. During first quarter 2022 earnings calls with invest…
Decline in COVID-19 Test Orders Signals a Shift
By Robert Michel | From the Volume XXIX, No. 5 – April 4, 2022 Issue
MIGHT THE FEDERAL HEALTHCARE ESTABLISHMENT BE CLOSE TO DECLARING AN END TO THE SARS-COV2 PANDEMIC and—given the ongoing decline in the daily number of new cases and deaths—that COVID-19 is expected to become an endemic disease? The SARS-CoV-2 statis…
COVID-19: a Fork in the Road for Future Lab Testing?
By R. Lewis Dark | From the Volume XXIX, No. 4 – March 14, 2022 Issue
We have all experienced a pandemic unique in the history of the world. Two elements, in particular, distinguished this pandemic from earlier global outbreaks. First, genetic technologies allowed scientists to almost instantly sequence the DNA of the novel coronavirus, once it was recognized as a uniq…
How Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized